Mesirow Financial Investment Management’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$427K Hold
42,481
0.01% 387
2026
Q1
$269K Buy
42,481
+6,000
+16% +$38.4K ﹤0.01% 452
2025
Q4
$224K Buy
36,481
+24,303
+200% +$143K ﹤0.01% 447
2025
Q3
$76.1K Hold
12,178
﹤0.01% 544
2025
Q2
$84.8K Hold
12,178
﹤0.01% 520
2025
Q1
$58.3K Sell
12,178
-12,178
-50% -$62.5K ﹤0.01% 578
2024
Q4
$125K Buy
24,356
+12,178
+100% +$48.5K ﹤0.01% 569
2024
Q3
$44.2K Hold
12,178
﹤0.01% 578
2024
Q2
$59.1K Hold
12,178
﹤0.01% 494
2024
Q1
$64.5K Hold
12,178
﹤0.01% 504
2023
Q4
$62K Buy
+12,178
New +$59.4K ﹤0.01% 542

Other funds holding ICCC

Mesirow Financial Investment Management's ICCC Position: Q2 2026 in Review

Mesirow Financial Investment Management held its ImmuCell (ICCC) position steady in Q2 2026 at 42,481 shares worth $427K. The position accounts for 0.01% of the portfolio, ranked #387.

Mesirow Financial Investment Management first reported a position in ICCC in Q4 2023 and has held it in 11 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Mesirow Financial Investment Management held 42,481 shares of ImmuCell worth $427K as of Q2 2026.
  • Mesirow Financial Investment Management left its ImmuCell share count unchanged in Q2 2026.
  • ImmuCell made up 0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #387 holding.
  • Mesirow Financial Investment Management first reported a position in ImmuCell in Q4 2023 and has held it in 11 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.